| Ytd | -30.23% | |
| 1y | -26.17% |
| Open | 87.46 | Prev Close | 88.43 | Low | 82.55 | High | 88.00 | Mkt Cap | 2.94B |
| Vol | 1.19M | Avg Vol | 969.03K | EPS | 3.71 | P/E | 22.88 | Forward P/E | 36.81 |
| Beta | 1.88 | Short Ratio | 8.19 | Inst. Own | 103.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 79.24 | 200-d Avg | 105.54 | 1yr Est | 97.30 |
TMDX News
ANDOVER, Mass., Aug. 31, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX)
NEW YORK, Aug. 29, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, conti
/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the l
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
Emerald Investment Advisers LLC bought a new stake in shares of TransMedics Group, Inc. (NASDAQ: TMD
NEW YORK, Aug. 21, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues
Moderna jumped 177% on a cancer-vaccine first, plus retail's reversal
New York, New York--(Newsfile Corp. - August 19, 2026) - WHY: Rosen Law Firm, a global investor righ
NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues
GOOG buys data to aid AI models, Tesla gets closer to formal Cybercab launch, and more
TransMedics Group NASDAQ: TMDX outlined its growth strategy at Canaccord Genuity's 46th Annual Globa
NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, conti
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of [url=
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr.,
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
A Deep Dive into the Small-Cap Pioneer's Latest Moves, Including a -0.42% Impact from Exiting a Majo
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, annou
NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues
NEW YORK, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, annou
On August 06, 2026, TransMedics Group Inc (TMDX) shares rose 4.9%, bringing the current price to $80
TransMedics Group, Inc. (NASDAQ: TMDX - Get Free Report) shares gapped down prior to trading on Wedn
UBS analyst Patrick Wood maintains TransMedics Group (NASDAQ:TMDX) with a Neutral and lowers the
Piper Sandler analyst Matt O'Brien reiterates TransMedics Group (NASDAQ:TMDX) with a Overweig
U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 reve
TransMedics Group (NASDAQ:TMDX) raises FY2026 sales outlook from $727.000 million-$757.000 million t
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.44 per share which missed the analyst
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the p
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outp
TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ:TMDX) with a Buy and mainta
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the p
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the p
Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy a
TD Cowen analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers th
Piper Sandler analyst Matt O'Brien maintains TransMedics Group (NASDAQ:TMDX) with a Overweigh
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the p
U.S. stock futures up, Dow gains 200 points. Upstart (UPST) falls 11.8% on weak Q1 EPS and FY26 sale
Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affir
TransMedics Group (NASDAQ:TMDX) affirms FY2026 sales outlook from $727.000 million-$757.000 million
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.30 per share which missed the analyst
The proposed strategic investment is subject to the satisfaction of closing conditions specified in
Unveils New Controlled Hypothermic Organ Preservation System (CHOPS) to Expand its Product Portfolio
Choice Hotels, Avis Budget and Lucid stock all have short-interest above 50% of their free floats.
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outp